Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2025 07:30 ET | Source: ElevateBio

ElevateBio Announces Compelling Preclinical Data Demonstrating the Potential of LETI-101 as a Treatment for Huntington's Disease

- LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential wild-type HTT in a clinically relevant Huntington’s...
January 09, 2025 07:30 ET | Source: ElevateBio

ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ElevateBio will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:00 a.m. PST.
November 04, 2024 07:30 ET | Source: ElevateBio

ElevateBio Appoints Amy Pooler, Ph.D., as Senior Vice President, Research and Development

ElevateBio Appoints Amy Pooler, Ph.D., as Life Edit’s Senior Vice President, Research and Development
October 16, 2024 07:30 ET | Source: ElevateBio

ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential

ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential
May 14, 2024 07:00 ET | Source: ElevateBio

ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabling Advanced Gene Editing Techniques

- Issued patents provide protection for multiple of Life Edit’s lead adenine deaminases, base editors, and RNA-guided nucleases with applications in base editing and reverse transcriptase editing - ...